Potential Off-Target Interaction of the Amyloid PET Imaging Tracer PiB with Acetylcholinesterase

Pittsburgh compound B (PiB) is a widely used Positron Emission Tomography (PET) tracer for detecting amyloid-β (Aβ) deposits in Alzheimer's disease (AD). While PiB is assumed to bind selectively to Aβ, emerging evidence suggests off-target interactions that may complicate PET signal interpretation. Here, we report that PiB can interact with acetylcholinesterase (AChE), a key enzyme in the cholinergic system. Similarity screening identified the AChE ligand thioflavin T (ThT) as the top structural analogue of PiB. Docking studies and molecular dynamics simulations showed that PiB stably binds the peripheral anionic site (PAS) of AChE, with binding energies comparable to ThT and clinically relevant AChE inhibitors. <i>In vitro</i> fluorescence-based assays confirmed this interaction and suggest an involvement of the PAS. These findings indicate a plausible, stable off-target interaction between PiB and AChE with implications for interpreting PiB-PET signals in AD, particularly in reference regions with altered AChE expression or under AChE inhibitor therapy.

Authors

Institutions

Publication Details

Journal
ACS Omega
Published
2025-10-10
DOI
https://doi.org/10.1021/acsomega.5c06188
Primary Topic
Computational Drug Discovery Methods
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Potential Off-Target Interaction of the Amyloid PET Imaging Tracer PiB with Acetylcholinesterase

Manuela Bomba, Stefano Luca Sensi, Alberto Granzotto, Giuseppe Floresta et al.
ACS Omega
Computational Drug Discovery Methods
article

Potential Off-Target Interaction of the Amyloid PET Imaging Tracer PiB with Acetylcholinesterase

Manuela Bomba, Stefano Luca Sensi, Alberto Granzotto, Giuseppe Floresta, Rosa Fullone, Stefano Delli Pizzi, Ludovico Miccoli, Claudia Di Marzio
article en

Abstract

Pittsburgh compound B (PiB) is a widely used Positron Emission Tomography (PET) tracer for detecting amyloid-β (Aβ) deposits in Alzheimer's disease (AD). While PiB is assumed to bind selectively to Aβ, emerging evidence suggests off-target interactions that may complicate PET signal interpretation. Here, we report that PiB can interact with acetylcholinesterase (AChE), a key enzyme in the cholinergic system. Similarity screening identified the AChE ligand thioflavin T (ThT) as the top structural analogue of PiB. Docking studies and molecular dynamics simulations showed that PiB stably binds the peripheral anionic site (PAS) of AChE, with binding energies comparable to ThT and clinically relevant AChE inhibitors. <i>In vitro</i> fluorescence-based assays confirmed this interaction and suggest an involvement of the PAS. These findings indicate a plausible, stable off-target interaction between PiB and AChE with implications for interpreting PiB-PET signals in AD, particularly in reference regions with altered AChE expression or under AChE inhibitor therapy.

ACS OmegaVol. 10(41)
University of Hertfordshire (GB), University of Catania (IT), University of Chieti-Pescara (IT), Drug Discovery Laboratory (Norway) (NO)
Openalex Percentile: Top 70%
Computational Drug Discovery Methods
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.